Variability in COVID-19 Vaccine Response Among People With Cancer: What Health Care Strategy Best Protects the Vulnerable?

Michael Hoerger^{1

2

3

4}, James Gerhart⁵, Maria C Swartz⁶

Affiliations

¹ Tulane Cancer Center, Tulane University, New Orleans, Louisiana.
² Departments of Psychology and Medicine (Hematology and Oncology), Tulane University, New Orleans, Louisiana.
³ A. B. Freeman School of Business, Tulane University, New Orleans, Louisiana.
⁴ Department of Palliative and Supportive Medicine, University Medical Center, New Orleans, Louisiana.
⁵ Department of Psychology, Central Michigan University, Mount Pleasant.
⁶ Department of Pediatrics-Research, University of Texas, MD Anderson Cancer Center, Houston.

Comment

Michael Hoerger et al. JAMA Oncol. 2023.

. 2023 Feb 1;9(2):177-179.

doi: 10.1001/jamaoncol.2022.5874.

Michael Hoerger^{1

2

3

4}, James Gerhart⁵, Maria C Swartz⁶

¹ Tulane Cancer Center, Tulane University, New Orleans, Louisiana.
² Departments of Psychology and Medicine (Hematology and Oncology), Tulane University, New Orleans, Louisiana.
³ A. B. Freeman School of Business, Tulane University, New Orleans, Louisiana.
⁴ Department of Palliative and Supportive Medicine, University Medical Center, New Orleans, Louisiana.
⁵ Department of Psychology, Central Michigan University, Mount Pleasant.
⁶ Department of Pediatrics-Research, University of Texas, MD Anderson Cancer Center, Houston.

No abstract available

Comment in

Evidence Base for Health Care Strategies to Protect Vulnerable Patients During the COVID-19 Pandemic.
Haslam A, Prasad V. Haslam A, et al. JAMA Oncol. 2023 Aug 1;9(8):1150. doi: 10.1001/jamaoncol.2023.1517. JAMA Oncol. 2023. PMID: 37261802 No abstract available.

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
Lee LYW, Tilby M, Starkey T, Ionescu MC, Burnett A, Hattersley R, Khan S, Little M, Liu JKH, Platt JR, Tripathy A, Watts I, Williams ST, Appanna N, Al-Hajji Y, Barnard M, Benny L, Buckley A, Cattell E, Cheng V, Clark J, Eastlake L, Gerrand K, Ghafoor Q, Grumett S, Harper-Wynne C, Kahn R, Lee AJX, Lydon A, McKenzie H, Panneerselvam H, Pascoe J, Patel G, Patel V, Potter V, Randle A, Rigg AS, Robinson T, Roylance R, Roques T, Rozmanowski S, Roux RL, Shah K, Sintler M, Taylor H, Tillett T, Tuthill M, Williams S, Beggs A, Iveson T, Lee SM, Middleton G, Middleton M, Protheroe AS, Fittall MW, Fowler T, Johnson P; UK COVID Cancer Programme. Lee LYW, et al. JAMA Oncol. 2023 Feb 1;9(2):188-196. doi: 10.1001/jamaoncol.2022.5974. JAMA Oncol. 2023. PMID: 36547970 Free PMC article.